| Title |
Standard No. |
Implemented On |
| SN/T 0000-1997 General rules for drafting the standard methods for the determination of pesticide veterinary drug residues and biotoxins in commodities for export | SN/T 0000-1997 | |
| Analytical method and evaluation requirements for antibacterial drugs in disinfectant and antibacterial and bacteriostatic agents | WS/T 684-2020 | 2021-2-1 |
| Analytical method and evaluation requirements of antifungal drugs in disinfectant and antibactertial and bacteriostatic agents | WS/T 685-2020 | 2021-2-1 |
| Analytical method and evaluation requirements of antiviral drugs in disinfectant and antibacterial and bacteriostatic agents | WS/T 686-2020 | 2021-2-1 |
| Hygienic requirements for alcohol-based disinfectant | GB/T 26373-2020 | 2020-12-1 |
| General requirements on disinfectant for infectious focus | GB 27953-2020 | 2020-11-1 |
| Terminology for transfusion medicine | WS 203-2020 | 2020-11-1 |
| Guidelines of venous blood specimen collection | WS/T 661-2020 | 2020-10-1 |
| Technical requirements for clinical body fluids analysis | WS/T 662-2020 | 2020-10-1 |
| Technical regulation for preventive disinfection in flood and waterlogged area | WS/T 700-2020 | 2020-7-23 |
| Technical regulation of hygiene for packing and transporting of corpse | MZ/T 135-2019 | 2019-12-12 |
| Hygienic requirement for medical purpose-low temperature steam and formaldehyde sterilizers | WS/T 649-2019 | 2019-7-1 |
| Evaluting Method for Efficacy of Antibacterial and Bacteriostasis | WS/T 650-2019 | 2019-7-1 |
| Specimen collection and transport in clinical microbiology | WS/T 640-2018 | 2019-6-1 |
| Reference intervals for common clinical immunology tests Part 1:Serum immunoglobulin G, immunoglobulin A,immunoglobulin M, Complement 3,Complement 4 | WS/T 645.1-2018 | 2019-6-1 |
| External Quality Assessment/Proficiency Testing in Clinical Laboratory | WS/T 644-2018 | 2019-6-1 |
| Reference intervals for common clinical immunology tests Part 2: Serum a-fetoprotein, carcinoembryonic antigen, carbohydrate antigen 19-9，carbohydrate antigen 15-3, carbohydrate antigen 125 | WS/T 645.2-2018 | 2019-6-1 |
| Common used serum tumor marker tests:clinical practice and quality management | WS/T 459-2018 | 2019-6-1 |
| Reference intervals for common clinical biochemistry tests Part 9: Serum C-reactive protein, prealbumin, transferrin,β2一microglobulin | WS/T 404.9-2018 | 2019-6-1 |
| Technical specification on antimicrobial susceptibility tests | WS/T 639-2018 | 2019-6-1 |
| Hygienic requirements for disinfectants with chlorine | GB/T 36758-2018 | 2019-4-1 |
| Reference procedure for the measurement of catalytic activity concentration of aspartate aminotransferase | WS/T 617-2018 | 2019-3-1 |
| Autoverification of Clinical Laboratory Quantitative Test Results | WS/T 616-2018 | 2019-3-1 |
| Purified reagent water in the clinical laboratory | WS/T 574-2018 | 2018-11-1 |
| Performance verification of vacuum tubes for venous blood specimen | WS/T 224-2018 | 2018-11-1 |
| Algorithm and report of immunological testing for infectious diseases | WS/T 573-2018 | 2018-11-1 |
| Guideline for performance characteristics of immunological qualitative test | WS/T 494-2017 | 2018-3-1 |
| Guide to the estimation of the measurement uncertainty of reference methods in enzymology reference laboratiories | WS/T 493-2017 | 2018-3-1 |
| Guideline for evaluation of qualitative test performance | WS/T 505-2017 | 2018-3-1 |
| Operating procedures of blood culture for linical microbiology laboratory | WS/T 503-2017 | 2018-3-1 |
| Rapid detection methods on site for disinfectant used in medical and health | WS/T 535-2017 | 2018-2-1 |
| Establishment and verification of detection capability for clinical laboratory measurement procedures | WS/T 514-2017 | 2017-7-1 |
| Performance guideline for clinical laboratory diagnosis of invasive fungal diseases | WS/T 497-2017 | 2017-7-1 |
| Performance guideline for clinical laboratory diagnosis of bacterial diarrhea | WS/T 498-2017 | 2017-7-1 |
| Performance guideline for bacterial culture of lower respiratory tract infections | WS/T 499-2017 | 2017-7-1 |
| Quality indicators in clinical laboratories | WS/T 496-2017 | 2017-7-1 |
| Test method of chemical indicator for ethylene oxide sterilization processes | GB/T 33418-2016 | 2017-7-1 |
| Test method of biological indicator for hydrogen peroxide vapour sterilization processes | GB/T 33417-2016 | 2017-7-1 |
| Test method of biological indicator for ethylene oxide sterilization processes | GB/T 33419-2016 | 2017-7-1 |
| Evaluation standard of biological for moist heat sterilization processes | GB/T 33420-2016 | 2017-7-1 |
| Classification and codes of diseases | GB/T 14396-2016 | 2017-2-1 |
| Laboratory diagnosis of urinary tract infections | WS/T 489-2016 | 2016-12-15 |
| Guideline to calibration of clinical chemistry measurement system | WS/T 490-2016 | 2016-12-15 |
| Verification of performance for precision and trueness of quantitative measurements in clinical laboratories | WS/T 492-2016 | 2016-12-15 |
| Guideline of test method of non-specific antibodies for treponemal pallidum infection | WS/T 491-2016 | 2016-12-15 |
| Quantitative D-dimer assay | WS/T 477-2015 | 2016-5-1 |
| Operating guidelines for measurement of serum 25-hydroxvitamin D3-Isotope dilution liquid chromatography tandem mass spectrometry | WS/T 478-2015 | 2016-5-1 |
| Oral health survey―Examination methods | WS/T 472-2015 | 2016-2-1 |
| General principle on disinfection for infectious focus | GB 19193-2015 | 2016-1-1 |
| Measurement of Hemoglobin A1c | WS/T 461-2015 | 2015-12-31 |
| Measurement of serum low density lipoprotein cholesterol | WS/T 463-2015 | 2015-12-31 |
| Clinical practice of PSA test in prostatic cancer | WS/T 460-2015 | 2015-12-31 |
| Clinical practice of cardiac markers in coronary artery disease and heart failure | WS/T 462-2015 | 2015-12-31 |
| Reference intervals for common clinical biochemistry tests—Part 5:Serum urea and creatinine | WS/T 404.5-2015 | 2015-10-1 |
| Reference intervals for common clinical biochemistry tests—Part 6:Serum calcium,phosphorus,magnesium,iron | WS/T 404.6-2015 | 2015-10-1 |
| Quality control for radiation sterilization of medical and hygienical products | GB 16383-2014 | 2015-7-1 |
| Clinical Use of Tests for Toxoplasma Gondii | GB/T 30224-2013 | 2014-12-1 |
| Nursing classification | WS/T 431-2013 | 2014-5-1 |
| Determination of blood lead and cadmium—Tungsten ship atomic absorption spectrometric method | WS/T 443-2013 | 2014-5-1 |
| Nursing practice standards for intravenous therapy | WS/T 433-2013 | 2014-5-1 |
| Reference measurement method for serum triglycerides-Isotope dilution gas chromatography mass spectrometry | WS/T 412-2013 | 2013-12-1 |
| Antifungal susceptibiliy testing of filamentous fungi-Broth dilution ethod | WS/T 411-2013 | 2013-12-1 |
| Reference mesurement method for serum creatinine-Isotope dilution liquid chromatography tandem mass spectrometry | WS/T 414-2013 | 2013-12-1 |
| Mearuements of serum high density lipoprotein cholesterol | WS/T 410-2013 | 2013-12-1 |
| Assessment of laboratory tests when proficiency testing is not available | WS/T 415-2013 | 2013-12-1 |
| Estimation of total analytical error for clinical laboratory methods | WS/T 409-2013 | 2013-12-1 |
| Reference mesurement method for serum creatinine-Isotope dilution liquid chromatography tandem mass spectrometry | WS/T 413-2013 | 2013-12-1 |
| Reference intervals for common clinical biochemistry tests—Part 3:Serum potassium,sodium and chloride | WS/T 404.3-2012 | 2013-8-1 |
| Define and determine the reference intervals in clinical laboratory | WS/T 402-2012 | 2013-8-1 |
| Guide to linearity evaluation of clinical chemistry analyzers | WS/T 408-2012 | 2013-8-1 |
| Guideline for comparability verification of quantitative results within one health care system | WS/T 407-2012 | 2013-8-1 |
| Reference intervals for common clinical biochemistry tests—Part 1:Serum alanine aminotransferase,aspartate aminotransferase,alkaline phosphatase and γ-glutamyltansferase | WS/T 404.1-2012 | 2013-8-1 |
| Analytical quality specifications for routine analytes in clinical biochemistry | WS/T 403-2012 | 2013-8-1 |
| Reference intervals for blood cell analysis | WS/T 405-2012 | 2013-8-1 |
| Analytical quality specifications for routine tests in clinical hematology | WS/T 406-2012 | 2013-8-1 |
| Reference intervals for common clinical biochemistry tests—Part 2:Serum total protein and albumin | WS/T 404.2-2012 | 2013-8-1 |
| Clinical practice guidelines of bone metabolic markers | WS/T 357-2011 | 2012-6-1 |
| Guideline for evaluation of matrix effects and commutability | WS/T 356-2011 | 2012-6-1 |
| Reference measurement procedure for serum cholesterol—Spectrophotometry | WS/T 362-2011 | 2012-6-1 |
| Guidelines for enzymatic measurements of serum triglycerides | WS/T 355-2011 | 2012-6-1 |
| Reference procedure for the measurement of catalytic activity concentration of lactate dehydrogenase | WS/T 361-2011 | 2012-6-1 |
| Collection and processing of blood specimens for testing plasma-based coagulation assays | WS/T 359-2011 | 2012-6-1 |
| Guidelines for peripheral lymphocyte subsets by flow cytometry | WS/T 360-2011 | 2012-6-1 |
| Collection and processing of urine specimens | WS/T 348-2011 | 2012-4-1 |
| Reference procedure of the measurement of urea in serum | WS/T 345-2011 | 2012-4-1 |
| Reference procedure for the measurement of catalytical activity concentration of alkaline phosphatase (ALP) | WS/T 351-2011 | 2012-4-1 |
| Reference procedure for the measurement of catalytic activity concentration of alanine aminotransferase(No pyridoxal-5-phosphoric acid) | WS/T 352-2011 | 2012-4-1 |
| Reference method for the erythrocyte sedimentation rate(ESR) | WS/T 343-2011 | 2012-4-1 |
| Reference method for reticulocyte counting | WS/T 346-2011 | 2012-4-1 |
| Reference procedure of the measurement of glucose in serum | WS/T 350-2011 | 2012-4-1 |
| Guideline for the calibration of blood cell assays | WS/T 347-2011 | 2012-4-1 |
| Reference procedure for the measurement of catalytic activity concentration of α-amylase | WS/T 349-2011 | 2012-4-1 |
| Reference method for hematocrit | WS/T 342-2011 | 2012-4-1 |
| Reference method for haemoglobinometry in human blood | WS/T 341-2011 | 2012-4-1 |
| Reference procedure for the measurement of catalytic activity concentration of aspartate aminotransferase(No pyridoxal-5’-phosphoric acid) | WS/T 353-2011 | 2012-4-1 |
| Guideline for the bleeding time test | WS/T 344-2011 | 2012-4-1 |
| Immunoassay of serum or plasma lipoprotein(a) | WS/T 358-2011 | 2012-1-1 |
| Requirements of external quality assessment for clinical laboratories | GB/T 20470-2006 | 2007-2-1 |
| General guideline of the clinical laboratory design | GB/T 20469-2006 | 2007-2-1 |
| Guideline for internal quality control for quantitative measurements in clinical laboratory | GB/T 20468-2006 | 2007-2-1 |
| Approved Guideline of Systems for Alpha Fetoprotein(AFP) Assays Used Prenatal Screening and Diagnosis of Open Neural Tube Defects | WS/T 247-2005 | 2005-12-1 |
| Reference leukocyte differential count method | WS/T 246-2005 | 2005-12-1 |
| Guidelines for Clinical Laboratory Safety | WS/T 251-2005 | 2005-12-1 |
| Labeling of In Vitro Diagnosis Products | WS/T 252-2005 | 2005-12-1 |
| In vitro diagnostic medical devices-Measurement of quantities in samples of biological origin-Presentation of reference measurement procedures | WS/T 254-2005 | 2005-12-1 |
| Clinical Laboratory Waste Management | WS/T 249-2005 | 2005-12-1 |
| Clinical laboratory medicine-Requirements for reference measurement laboratories | WS/T 255-2005 | 2005-12-1 |
| In vitro diagnostic medical devices-Measurement of quantities in samples of biological origin-Description of reference materials | WS/T 253-2005 | 2005-12-1 |
| Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria | WS/T 248-2005 | 2005-12-1 |
| General biosafety standard for microbiological and biomedical laboratories | WS 233-2002 | 2003-8-1 |
| Protocols for the evaluation of dehydrated Mueller-Hinton agar in the disk diffusion procedure for antimicrobial susceptibility testing | WS/T 231-2002 | 2002-7-1 |
| Evacuated tubes and additives for blood speciment collection | WS/T 224-2002 | 2002-7-1 |
| Collection and processing of blood speciments for clinical chemistry | WS/T 225-2002 | 2002-7-1 |
| Preliminary evaluation of quantitative clinical laboratory methods | WS/T 228-2002 | 2002-7-1 |
| Performance standard of quality assurance for commercially prepared microbiological culture media | WS/T 232-2002 | 2002-7-1 |
| Guidelines for enzyme immuno-assay of hepatits B surface antigen | WS/T 223-2002 | 2002-7-1 |
| Physical,chemical and microscopic examination of urine | WS/T 229-2002 | 2002-7-1 |
| Requirement for the technical procedure manual in clinical laboratory | WS/T 227-2002 | 2002-7-1 |
| Guidelines for immunoprecipitin analyses--Procedures for evaluating the performance of materials | WS/T 221-2002 | 2002-7-1 |
| Guideline for the measurement of catalytic concentration of clinical enzymes | WS/T 222-2002 | 2002-7-1 |
| Guidelines for use of polymerase chain reaction (PCR) technique in clinical diagnosis | WS/T 230-2002 | 2002-7-1 |
| Guidelines for blood glucose testing by using portable blood glucose meter | WS/T 226-2002 | 2002-7-1 |
| and codes of diseases | GB/T 14396-2001 | 2002-6-1 |
| Standard terminology for blood transfusion medicine | WS/T 203-2001 | 2002-1-1 |
| Inspection criteria of the quality of clinical chemistry in vitro diagnostic kits - General guideline | WS/T 124-1999 | 2000-5-1 |
| Determination of hematocrit | WS/T 123-1999 | 2000-5-1 |
| Standard of antidbiotics susceptibility test (kirby-bauer method) | WS/T 125-1999 | 2000-5-1 |
| Guidelines for enzymatic measurements of blood serum total cholesterol | WS/T 120-1999 | 2000-5-1 |
| Quantitative determination of hemoglobin in whole blood | WS/T 122-1999 | 2000-5-1 |
| Criteria for evaluation of effect of water supply improvement and defluoridation measures | WS/T 90-1996 | 1997-9-1 |
